Cargando…

Liver Disease in Singapore

Liver disease is a significant health issue in Singapore. In the Singapore Burden of Disease Survey, liver cancer and liver cirrhosis contributed 3.2 and 0.9% of years of life lost (YLL) out of 182,753 YLL respectively. Liver cancer was ranked 8th and liver cirrhosis was ranked 20th in YLL. Liver ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Muthiah, Mark, H Chong, Chern, G Lim, Seng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024054/
https://www.ncbi.nlm.nih.gov/pubmed/29963466
http://dx.doi.org/10.5005/jp-journals-10018-1262
_version_ 1783335984732045312
author Muthiah, Mark
H Chong, Chern
G Lim, Seng
author_facet Muthiah, Mark
H Chong, Chern
G Lim, Seng
author_sort Muthiah, Mark
collection PubMed
description Liver disease is a significant health issue in Singapore. In the Singapore Burden of Disease Survey, liver cancer and liver cirrhosis contributed 3.2 and 0.9% of years of life lost (YLL) out of 182,753 YLL respectively. Liver cancer was ranked 8th and liver cirrhosis was ranked 20th in YLL. Liver cancer is the 5th most common cancer in males, and has an age-adjusted rate of 17.6 per 100,000 population. The underlying etiology of liver cirrhosis is chronic hepatitis B (CHB) in 63.3%, alcohol in 11.2%, cryptogenic in 9%, and chronic hepatitis C (CHC) in 6.9%. The overall seroprevalence rate of CHB is 3.6%, while CHC is approximately 0.1%. The trend in prevalence of liver cancer is gradually reducing as is CHB. However, less is known about alcoholic liver disease and fatty liver disease and there is some evidence that the latter is increasing. Singapore has a multilayered health care system designed to provide basic health care needs to the population. There are various schemes available that provide subsidized and assisted health care for treatment of hepatitis B and C as well as liver transplantation. Health policy with regard to a national action plan has not yet been developed and there is room for health care specialists, government and nongovernment agencies to work together to tackle liver disease in Singapore. How to cite this article: Muthiah M, Chong CH, Lim SG. Liver Disease in Singapore. Euroasian J Hepato-Gastroenterol 2018;8(1):66-68.
format Online
Article
Text
id pubmed-6024054
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-60240542018-06-30 Liver Disease in Singapore Muthiah, Mark H Chong, Chern G Lim, Seng Euroasian J Hepatogastroenterol Mini-Review Liver disease is a significant health issue in Singapore. In the Singapore Burden of Disease Survey, liver cancer and liver cirrhosis contributed 3.2 and 0.9% of years of life lost (YLL) out of 182,753 YLL respectively. Liver cancer was ranked 8th and liver cirrhosis was ranked 20th in YLL. Liver cancer is the 5th most common cancer in males, and has an age-adjusted rate of 17.6 per 100,000 population. The underlying etiology of liver cirrhosis is chronic hepatitis B (CHB) in 63.3%, alcohol in 11.2%, cryptogenic in 9%, and chronic hepatitis C (CHC) in 6.9%. The overall seroprevalence rate of CHB is 3.6%, while CHC is approximately 0.1%. The trend in prevalence of liver cancer is gradually reducing as is CHB. However, less is known about alcoholic liver disease and fatty liver disease and there is some evidence that the latter is increasing. Singapore has a multilayered health care system designed to provide basic health care needs to the population. There are various schemes available that provide subsidized and assisted health care for treatment of hepatitis B and C as well as liver transplantation. Health policy with regard to a national action plan has not yet been developed and there is room for health care specialists, government and nongovernment agencies to work together to tackle liver disease in Singapore. How to cite this article: Muthiah M, Chong CH, Lim SG. Liver Disease in Singapore. Euroasian J Hepato-Gastroenterol 2018;8(1):66-68. Jaypee Brothers Medical Publishers 2018 2018-05-01 /pmc/articles/PMC6024054/ /pubmed/29963466 http://dx.doi.org/10.5005/jp-journals-10018-1262 Text en Copyright © 2018; Jaypee Brothers Medical Publishers (P) Ltd. This work is licensed under a Creative Commons Attribution 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/
spellingShingle Mini-Review
Muthiah, Mark
H Chong, Chern
G Lim, Seng
Liver Disease in Singapore
title Liver Disease in Singapore
title_full Liver Disease in Singapore
title_fullStr Liver Disease in Singapore
title_full_unstemmed Liver Disease in Singapore
title_short Liver Disease in Singapore
title_sort liver disease in singapore
topic Mini-Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024054/
https://www.ncbi.nlm.nih.gov/pubmed/29963466
http://dx.doi.org/10.5005/jp-journals-10018-1262
work_keys_str_mv AT muthiahmark liverdiseaseinsingapore
AT hchongchern liverdiseaseinsingapore
AT glimseng liverdiseaseinsingapore